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Recognition of NKG2D ligands by natural killer (NK)
cells plays an important role during antitumoral
responses. To address how NKG2D engagement
affects intratumoral NK cell dynamics, we performed
intravital microscopy in a Rae-1b-expressing solid
tumor. This NKG2D ligand drove NK cell accumula-
tion, activation, and motility within the tumor. NK
cells established mainly dynamic contacts with their
targets during tumor regression. In sharp contrast,
cytotoxic T lymphocytes (CTLs) formed stable
contacts in tumors expressing their cognate antigen.
Similar behaviors were observed during effector
functions in lymph nodes. In vitro, contacts between
NK cells and their targets were cytotoxic but did not
elicit sustained calcium influx nor adhesion, whereas
CTL contact stability was critically dependent on
extracellular calcium entry. Altogether, our results
offer mechanistic insight into how NK cells and
CTLs can exert cytotoxic activity with remarkably
different contact dynamics.
INTRODUCTION
Natural killer (NK) cells are endowed with the ability to directly
eliminate transformed or infected cells and are also able to regu-
late adaptive immune responses through cytokine production
(Yokoyama et al., 2004). NK cell recognition of target cells is
mediated by a balance between inhibiting and activating signals
(Lanier, 2005). NKG2D is a well-characterized activating
receptor of the lectin-like family (Burgess et al., 2008) expressed
by NK cells, most NKT cells, and subsets of T cells (Raulet,
2003). NKG2D recognizes a variety of ligands distantly related
to MHC class I proteins, namely members of the retinoic acid
early-inducible-1 (RAE-1) family as well as H60 and MULT1 in
mice; MHC class I chain-related proteins (MICA and MICB);
andmembers of the RAET1 family (also called ULBPs) in humans
(Nausch and Cerwenka, 2008). These ligands are often overex-
pressed by tumor cells in both humans (Groh et al., 1999) and632 Immunity 33, 632–644, October 29, 2010 ª2010 Elsevier Inc.mice (Cerwenka et al., 2000; Diefenbach et al., 2000) as a result
of the direct effect of oncogenes (Routes et al., 2005) or through
chronic activation of the DNA damage response pathway
(Gasser et al., 2005). In vivo, ectopic expression of NKG2D
ligands induces the rejection of tumor cell lines by NK cells
(Cerwenka et al., 2001; Diefenbach et al., 2001) in a perforin-
dependent manner (Hayakawa et al., 2002; Smyth et al., 2004).
Furthermore, antibody-mediated blockade of the NKG2D
pathway has been shown to increase the susceptibility of mice
to methylcholanthrene-induced sarcoma (Smyth et al., 2005).
In this model, expression of NKG2D ligands was found to be
higher when the NK cell response was deficient, implying that
NK cells participate in tumor immunoediting (Dunn et al.,
2004). Finally, mice deficient for the receptor NKG2D showed
an accelerated tumor development in models of spontaneous
prostate adenocarcinoma and B cell lymphoma, but not in
MCA-induced sarcomas (Guerra et al., 2008). Altogether, these
data illustrate the important role of NK cells in the surveillance
and elimination of tumors expressing NKG2D ligands. However,
a number of important questions remain unanswered. In partic-
ular, how NKG2D ligand expression influences NK cell recruit-
ment and trafficking in solid tumors is still unknown. It is also
unclear how NK cells interact with targets within the tumor
microenvironment.
Using intravital two-photon imaging (Cahalan et al., 2002), we
and others have characterized the cellular dynamics of intratu-
moral cytotoxic T lymphocytes (CTLs) (Boissonnas et al., 2007;
Breart et al., 2008; Mrass et al., 2006). In the early phases of
tumor regression, CTL velocity was drastically reduced, with
many tumor-specific CTLs forming long-lasting contacts with
their targets in vivo (Boissonnas et al., 2007; Mrass et al.,
2006). Furthermore, tumor cell apoptosis was associated with
stable contacts with one or several CTLs (Breart et al., 2008).
Likewise, in vitro studies have shown that NK cells form stable
contacts with their targets during which lytic granules are
secreted at the interface of the effector and the target cell
(reviewed in Orange, 2008). However, whether stable interac-
tions also form in vivo has not yet been investigated.
To address these issues, we have combined intravital micros-
copy and amodel of Rae-1b- or, to investigate CTL activity, oval-
bumin-, expressing solid tumor (Diefenbach et al., 2001). We
show that NKG2D ligand expression promotes NK cell accumu-
lation, motility, and dissemination within the tumor. Surprisingly,
Figure 1. Rae-1b Expression by EL4 Tumor
Cells Results in Higher Intratumoral NK
Cell Density and Dissemination
(A) Growth of EL4 (filled squares) and EL4 Rae-1b
(open squares) tumors in wild-type C57BL/6 mice.
(B) Growth of EL4 Rae-1b tumors in Rag2/
Il2rg/ mice in the absence of NK cells (squares)
or after NK cell adoptive transfer 4 days before
(triangles) or after (circles) tumor injection. Data
are presented as mean ± SEM of three mice
and are representative of two independent experi-
ments.
(C and D) Four days after tumor injection, GFP-
expressing NK cells were transferred in Rag2/
Il2rg/ mice. Representative sections of EL4 (C)
and EL4 Rae-1b (D) tumors (red) showing infiltra-
tion of NK cells (yellow) were analyzed 4 days after
NK cell transfer. Blood vessels were stained with
anti-PECAM-1 mAb (white). Scale bars represent
100 mm.
(E) NK cell density in EL4 and EL4 Rae-1b tumors.
Each dot represents the NK cell density in one
775 3 775 3 10 mm section (p < 0.001).
(F) Percentage of NK cells in direct contact with
a blood vessel in EL4 and EL4 Rae-1b tumors
(p < 0.01).
(G) Percentages of NK1.1+ cells in the spleens of
reconstituted Rag2/Il2rg/ mice bearing an
EL4 or an EL4 Rae-1b tumor 4 days after NK cell
transfer (n.s., not significant, 3 mice per group).
Data are representative of at least two indepen-
dent experiments. Error bars represent SEM.
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Distinct Dynamics of NK and CD8+ T Cells in TumorsNK cells and CTLs exhibited strikingly different intratumoral
behavior with most NK cells forming short-lived and dynamic
contacts with tumor cells. Furthermore, we provide evidence
that distinct intensities of calcium elevation upon target recogni-
tion account for the different modes of interactions used by NK
cells and CTLs during effector function.
RESULTS
Rae-1bExpressionResults in Increased Intratumoral NK
Cell Density and Dissemination
To visualize the course of an NKG2D-dependent antitumor
response, we relied on EL4 tumor cells transduced to express
Rae-1b (Diefenbach et al., 2001). EL4 cells do not express
NKG2D ligands (Diefenbach et al., 2000) and were not rejected
in wild-type C57BL/6 recipients upon subcutaneous injection.
In contrast, EL4 Rae-1b cells were rejected before the formation
of a palpable tumor (Figure 1A), even after the injection of highImmunity 33, 632–644numbers of cells (up to 50 3 106, data
not shown), thus precluding analysis of in-
tratumoral immune responses. Because
rejection of EL4 Rae-1b tumors has been
shown to be NK cell-dependent on the
basis of depletion studies (Diefenbach
et al., 2001), we assessed their growth
in lymphocyte-deficient (T, B, and NK
cells)Rag2/Il2rg/mice (Colucci et al.,
1999). As expected, EL4 Rae-1b cellsformed solid tumors in Rag2/Il2rg/ animals (Figure 1B),
and this growth could be prevented by adoptive transfer of NK
cells purified by negative selection 4 days before tumor injection
(Figure 1B). In order to visualize NK cells within an established
tumor, we reconstituted Rag2/Il2rg/mice with 23 106 GFP
expressing NK cells 4 days after the injection of EL4 Rae-1b
cells. With this approach, we observed delayed tumor growth
at early time points (Figure 1B), thus providing us with a model
to study the response of NK cells in the context of a solid tumor.
As response through the NKG2D pathway may decrease NK cell
activity over time (Coudert et al., 2005), we chose to perform
experiments at the earliest time point at which the tumor could
be easily visualized, i.e., 4 days after NK cell transfer.
First, we quantified NK cell infiltration in solid EL4mCFP or EL4
Rae-1b mYFP tumors by confocal imaging of frozen tumor
sections (Figures 1C and 1D). NK cell density was markedly
increased in tumors expressing Rae-1b (1173 ± 189 cells/mm3)
compared to control tumors (301 ± 70 cells/mm3) (Figure 1E)., October 29, 2010 ª2010 Elsevier Inc. 633
Figure 2. Infiltrating NK Cells Display Hallmarks of Activation and Specifically Eliminate EL4 Rae-1b Tumor Cells
(A) GFP expressing NK cells were adoptively transferred in Rag2/Il2rg/ mice bearing an EL4 (top row) or an EL4 Rae-1b (bottom row) solid tumor. Forward
side scatter and intracellular granzyme B content of tumor infitrating (black lines) and splenic NK cells (gray area) were quantified by flow cytometry 4 days after
transfer. Cells were gated on live GFP+ NK1.1+ populations; isotype control is displayed in light gray. These results are representative of two independent exper-
iments, with three mice per group.
(B) NKG2D expression wasmeasured onGFP+NK1.1+ NK cells in spleen and tumors ofRag2/Il2rg/mice bearing an EL4 Rae-1b tumor (bottom row) or onNK
cells of wild-type naivemice (top row). Intratumoral NK cells are displayed as a black line, splenic NK cells are displayed as dark-gray filled histograms, and nega-
tive controls are displayed as light-gray filled histograms.
(C) Percentage of tumor surface occupied by EL4 Rae-1b cells eight days after the injection of a mixture of mCFP expressing EL4 and mYFP expressing EL4
Rae-1b cells. Each dot corresponds to one 775 3 775 3 10 mm section (p < 0.001).
(D and E) Representative images of mixed EL4 (red) and EL4 Rae-1b (green) tumors in the absence (D) or presence of transferred NK cells (E, NK cells in yellow
circles). Scale bars represent 100 mm.
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73 NK cells per million cells in EL4 tumors and 1798 ± 309 NK
cells per million cells in EL4 Rae-1b tumors. Interestingly, we
observed a wide range of cell densities, even within the same
tumor. Staining of blood vessels revealed that most NK cells
(70.0% ± 9.4%) were in direct contact with the vasculature in
control EL4 tumors. In contrast, NK cells were disseminated
throughout tumors expressing the NKG2D ligand, with only
29.9% ± 5.7% associated with vessels (Figure 1F). Of note, the
percentages of NK cells in spleens were similar in mice bearing
EL4 Rae-1b tumors and control EL4 tumors (Figure 1G). This
observation strongly suggested that the higher density of NK
cells in EL4 Rae-1b tumors was caused by an increased recruit-
ment to the tumor or an enhanced survival or proliferation in situ,
rather than systemic changes in the NK cell niche. Thus, this
experimental model allows the study of NK cells in tumors
expressing NKG2D ligands. Importantly, our data demonstrate634 Immunity 33, 632–644, October 29, 2010 ª2010 Elsevier Inc.that Rae-1b expression promotes NK cell accumulation and
dissemination in the tumor.
Tumor-Infiltrating NK Cells Display Hallmarks
of Activation and Cytotoxic Activity
To examine the impact of tumoral Rae-1b expression on NK cell
phenotype, we analyzed splenic and intratumoral NK cells by
flow cytometry 4 days after transfer. We noted that NK cells
were larger in EL4 Rae-1b tumors than in control EL4 tumors,
whereas the size of splenic NK cells were similar in mice bearing
EL4 and EL4 Rae-1b solid tumors (Figure 2A). We alsomeasured
expression of intracellular granzyme B in splenic and tumor-infil-
trating NK cells. Granzyme B expression was higher in intratu-
moral NK cells of mice bearing an EL4 Rae-1b solid tumor
(MFI of 2226 ± 770) as compared to splenic NK cells (MFI of
1158 ± 115) or NK cells present in control EL4 tumors (MFI of
1296 ± 89) (Figure 2A). Next, we assessed NKG2D amounts
Figure 3. NK Cell Motility in EL4 and EL4 Rae-1b Tumors
(A–C) Images from two-photonmovies representing transferredUBC-GFP NK cells (A) or endogenous Ncr1+/GFPNK cells (B) in an EL4 tumor or transferredUBC-
GFP NK cells in an EL4 Rae-1b (C) tumor. NK cells are pseudocolored in yellow, tumor cells in red. Tracks corresponding to the displacement of NK cells during
30 min of imaging are shown in white. Scale bars represent 30 mm.
(D) Mean velocity of NK cells in EL4 and EL4 Rae-1b tumors. Each dot represents an individual NK cell.
(E) Arrest coefficient of NK cells in EL4 and EL4 Rae-1b tumors. The arrest coefficient was defined as the percentage of time a cell is moving at a velocity lower
than 2 mm/min.
(F and G) Displacement of individual NK cells in EL4 (F, 21 cells) and EL4 Rae-1b (G, 35 cells) tumors; each track represents the displacement of a cell from its
starting point during 10 min. Data are representative of at least four movies in three independent experiments.
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compared to splenic NK cells, indicative of local receptor
engagement (Oppenheim et al., 2005) (Figure 2B). However,
expression of NKG2D was comparable on intratumoral NK cells
and naive splenic NK cells from awild-type animal (MFI of 1097 ±
198 and 930 ± 47 respectively), indicating that NKG2D was still
expressed to a substantial degree. Together, these results
strongly suggest that NK cells present in EL4 Rae-1b tumors
are activated locally and are potentially cytotoxic. To confirm
that NK cells exert cytotoxic activity on EL4 Rae-1b tumor cells,
we injected amixture of EL4mCFP and EL4 Rae-1bmYFP tumor
cells in Rag2/Il2rg/mice, reconstituted half of the recipients
with NK cells at day 4, and analyzed the tumor composition at
day 8 by confocal microscopy. The percentage of EL4 Rae-1b
tumor cells was drastically reduced in presence of NK cells
(from 26.5% ± 6.8% of tumor surface in control animals to
5.5% ± 2.0% after NK cell transfer) (Figures 2C–2E), demon-
strating that NK cells killed tumor cells expressing Rae-1b in
a specific manner. Collectively, these data demonstrate that
tumoral NKG2D ligand expression induces NK cell activation
in situ, and this ultimately results in efficient and specific target
cell lysis.
NKCells AreMotile in EL4 Rae-1b but Not in EL4 Tumors
To determine whether the dissemination of NK cells in EL4
Rae-1b tumors (Figure 1F) was the result of an increase inmotilityin situ, we performed intravital two-photon microscopy on solid
EL4 mCFP and EL4 Rae-1bmYFP tumors 4 days after the adop-
tive transfer of GFP-expressing NK cells. Strikingly, the motility
of the few infiltrating NK cells was extremely reduced in control
EL4 tumors, the mean velocity ranging from 0.3 to 1.6 mm/min
(Figures 3A and 3D and Movie S1 available online). Similarly,
when EL4 cells were injected in a wild-type Ncr1+/GFP mouse
(Gazit et al., 2006), endogenous NK cells also displayed immotile
behavior (Figure 3B and Movie S2), indicating that the transfer
was not the cause of the lack ofmotility of NK cells in EL4 tumors.
In sharp contrast, NK cells were motile when tumor cells
expressed Rae-1b, with a mean velocity of 5.2 ± 0.16 mm/min
(Figures 3C and 3D and Movie S3). We also quantified the arrest
coefficient of NK cells in both EL4 and EL4 Rae-1b, defined as
the percentage of time a cell is moving at less than 2 mm/min
(Boissonnas et al., 2007). NK cells were stopped more than
95% of the time in control EL4 tumors, whereas NK cells seldom
arrested when tumors expressed Rae-1b, with a mean arrest
coefficient of 23.8% ± 1.4% (Figure 3E). Interestingly, NK cell
velocities were strikingly similar in regions containing low or
high densities of NK cells, suggesting that the increased motility
is not just an enhanced freedom to move as a result of tumor cell
clearance (Figure S1). In agreement with these results, the
displacement of NK cells was also substantially higher in solid
tumors expressing the NKG2D ligand (Figures 3F and 3G). Over-
all, our data indicate that the expression of Rae-1b by tumor cellsImmunity 33, 632–644, October 29, 2010 ª2010 Elsevier Inc. 635
Figure 4. NK Cells but Not CD8+ T Cells Are Highly Motile in Tumor-rich Regions and Establish Short-Lasting Contacts with Their Targets
(A and B) Two-photon microscopy images representing OT-I CD8+ T cells in an EG7 mYFP tumor (A) or NK cells in an EL4 Rae-1bmYFP tumor (B). Effectors are
pseudocolored in yellow; tumor cells are shown in red. Scale bars represent 25 mm.
(C) Each dot represents the mean density of NK (upper graph) or T cells (lower graph) as a function of mean tumor signal in a given region. Data are expressed as
a percentage of the mean cell density of the movie.
(D and E) Schematic representation of EG7 (D) and EL4 Rae-1b (E) tumor cell-rich regions (red). Tracks representing the displacement of CTLs (D) and NK cells (E)
are shown in white.
(F) Mean velocity of NK (upper graph) or T cells (lower graph) as a function of mean tumor signal. Data are expressed as a percentage of the mean effector velocity
and tumor density of the movie.
(G) Contact durations between effectors and individual tumor cells. Contacts lasting for the whole movie are depicted as 30min long (3/130 for NK cells, 35/88 for
CTLs).
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ronment, a robust NK cell motility.
Intratumoral NK Cells Transiently Interact
with Their Targets
Given that CD8+ T cells and NK cells share similar mechanisms
to mediate cytotoxic activity (Russell and Ley, 2003), we
compared their behaviors in solid tumors. To study CTL-medi-
ated killing, we injected EL4 tumor cells expressing ovalbumin
(referred to as EG7) in Rag2/Il2rg/ and transferred activated
CD8+ T cells bearing the OT-I transgenic TCR. As previously
reported (Boissonnas et al., 2007; Breart et al., 2008; Mrass
et al., 2006), CTLs readily infiltrated the tumor, in which they
could subsequently be visualized by intravital two-photon
microscopy. To determine how tumor density influences NK
and T cell behavior, we quantified the number and velocity of
effectors in distinct areas of the tumor as a function of tumor
cell density. CTL density was markedly reduced in tumor cell-
rich areas (p < 0.001) and most CTLs were found in close prox-
imity to the border of such areas (Figures 4A and 4C; Movie S4
and Table S1). In contrast, the density of NK cells appeared
less dependent on tumor density, with even a small increase in
NK cell numbers in tumor cell-rich regions (p < 0.05) (Figures
4B and 4C and Movie S5). In agreement with these results, we
found decreased T cell motility in regions displaying a high tumor
cell density (p < 0.001), whereas mean NK cell velocity was
slightly increased in these regions (p < 0.01) (Figures 4D–4F
and Table S1). Furthermore, the quantification of the contact
durations between effector and tumor cells revealed that
T cells mainly establish long-lasting contacts, with more than
half of the interactions lasting more than 20 min. Strikingly, NK
cells interacted with their targets for much shorter periods.
Most NK cells indeed established contacts of either very short
or intermediate durations (48.9% of contacts lasted less than 5
min, 35% of contacts lasted from 5 to 10 min) (Figures 4G–4I).
To determine whether these differences in killing dynamics could
be extended to other contexts, we imaged NK cell and CTL
behaviors during killing of target cells (MHC-deficient and
peptide-pulsed splenocytes, respectively) in lymph nodes. We
also found sharp differences in the duration of the contacts
between effector cells and their specific targets, with NK cells
again only establishing short interactions, whereas T cells main-
tained prolonged contacts even with moving targets (Figure 5,
Figure S2, and Movies S6 and S7). In summary, the comparison
of NK and CD8+ T cell behavior in two distinct microenvirone-
ments revealed a sharp difference in the stability of effector-
target cell interactions. In tumors, this difference paralleled the
ability of NK cells to disseminate and maintain their motility,
whereas most CD8+ T cells are retained in interaction with their
targets at the border of tumor-rich regions.
NK Cells Form Fewer Stable Conjugates than CD8+
T Cells during Effector Function
To examine the possibility that differences in signaling underlie
the distinct behavior of NK and T cells, we performed in vitro(H and I) Representative time-lapse images of a contact between an NK cell and
(I, duration of 30min). Right-most panels represent cell trajectories (white) and tum
are representative of two to four independent experiments.conjugation experiments during which interaction conditions
can be more easily controlled. First, we quantified the formation
of effector-target cell conjugates by flow cytometry. After a 1 hr
co-culture, NK cells formed significantly less conjugates with
EL4 Rae-1b cells (12.9 ± 1.0%) than did OT-I T cells with EG7
tumor cells (44.9% ± 2.8%, p < 0.001). Nevertheless, NK cells
still formed significantly more contacts with cells expressing
Rae-1b than with controls (5.2% ± 0.6%, p < 0.001) (Figures
6A and 6B). Of note, we obtained similar results by using either
naive or perforin-deficient NK cells (data not shown), demon-
strating that the reduced NK conjugation was not due to the
activation status of the NK cells nor to the rapid death of their
targets. Given that these experiments measure the number of
conjugates that are stable enough to be detected during this
flow-based assay, our observations strongly suggest that
CD8+ T cells form more stable interactions with their targets
than do NK cells. Thus, results obtained with this in vitro model
are in agreement with the shorter durations of NK-EL4 Rae-1b
contacts observed in vivo. To formally exclude that differences
between tumor cells lines could account for the distinct contact
stabilities, we also tested conjugation of NK and OT-I T cells
to EL4 Rae-1b tumor cells loaded with the SIINFEKL peptide,
which can be recognized by both cell types. In this setting, we
also found strong differences in conjugation efficiency between
both cell types (10.8% ± 1.3% for NK cells, 48.65% ± 2.0% for
CTLs, data not shown). Thus, potential variability in the various
cell lines could not account for the disparate conjugation
efficiency of NK and CD8+ T cells. Additionally, we performed
similar experiments with a panel of transduced EG7 cell lines,
expressing distinct amounts of Rae-1b. Increasing expression
of this NKG2D ligand failed to rescue the low efficiency of stable
conjugates formed by NK cells, ruling out the possibility that
ligand levels were limiting in our experiments (Figure S2).
Furthermore, clustering efficiencies showed little variation over
a 1 to 6 hr time course (Figure 6C). Next, we evaluated the effi-
ciency of NK and CD8+ T cell cytotoxicity toward their respective
targets. Remarkably, NK cell killing was very efficient (up to
2-fold higher than CTL-mediated killing) over this 6 hr period
despite reduced clustering (Figure 6D). As reported previously
in other models of NKG2D-mediated recognition (Hayakawa
et al., 2002; Smyth et al., 2004), NK cell cytotoxicity was largely
impaired in perforin-deficient effectors (p < 0.001) (Figure 6E),
demonstrating that killing was dependent on perforin and
granzymes, and therefore primarily mediated during effector-
target interactions. Accordingly, we found that a substantial
percentage of unconjugated NK cells expressed CD107a, a
marker of recent degranulation (Figure 6F and Figure S3). This
would be consistent with the idea that someNK cells had already
performed their effector function anddetachedprior to conjugate
assesment. To test the possibility that the expression of an inhib-
itory receptor for a self-MHC molecule prevented NK cell conju-
gation and/or degranulation, we assessed the influence of the
expression of Ly49C and Ly49I receptors on NK cell responses
to EL4 Rae-1b tumor cells. Interestingly, NK cell conjugation
and degranulation in response to Rae1-b-expressing tumorsan EL4 Rae-1b tumor cell (H, duration of 270 s) or a CTL and an EG7 tumor cell
or cell position (red) at themedian time point. Scale bars represent 10 mm.Data
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Figure 5. NK Cells Establish Short-Lasting
Contacts during Elimination of MHC Class
I-Deficient Cells in Lymph Nodes
(A and B) Two-photon microscopy images repre-
senting NK cells interacting with B2m/ spleno-
cytes (A) or OT-I T cells interacting with SIIN-
FEKL-pulsed splenocytes (B) in intact lymph
nodes. Representative trajectories (effectors in
green, targets in red) are shown for cells establish-
ing contacts. Note that OT- I T cells maintain
stable contacts with moving targets (red and
green tracks are surperimposed) whereas NK
cells only interact for a brief period (tracks are in-
tercrossed). Scale bars represent 40 mm.
(C) Contact durations between either NK cells or
CTL and their respective targets were measured
from two-photon time-lapse movies (p < 0.001).
(D) Percentage of killed B2m/ splenocytes was
measured in vivo by flow cytometry in lymph no-
des with cotransferred wild-type splenocytes as
an internal control (p = 0.029). Data are represen-
tative of two independent experiments. Error bars
represent SEM.
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tors Ly49C and Ly49I (Figure 6G and Figure S3). These results
suggest that expression of Rae-1b largely overrides the effect
of inhibition in this system. Taken together, these results demon-
strate that altoughNKcells are at least as efficient asCD8+ T cells
in eliminating targets, they form substantially less stable interac-
tions during their killing activity.
NKCell ConjugationDoesNot InduceSustainedCalcium
Flux and Is Independent of Calcium Entry
Calcium signaling is an important step in lymphocyte activation
and function, and has also been associated with a stop signal
for migrating T cells in tissues (Bhakta et al., 2005). Therefore,
to assess whether conjugation with target cells was associated
with calcium influx, we loaded effector cells with a calcium-
sensitive dye, Fluo-3, and performed clustering assays after
a 10 min incubation with tumor cells. This method allowed us
to measure calcium concentrations simultaneously in the effec-
tors that were or were not engaged in conjugates. As expected,
the few effectors that were conjugated to control EL4 cells did638 Immunity 33, 632–644, October 29, 2010 ª2010 Elsevier Inc.not undergo calcium influx. More surpris-
ingly, althoughwe could observe a strong
and sustained calcium elevation in T cells
conjugated to EG7 tumor cells, calcium
responses of NK cells conjugated to
EL4 Rae-1b tumor cells were only slightly
above controls (Figure 7A). Strong
calcium responses were also observed
in CD8+ T cells interacting with peptide-
pulsed EL4 Rae-1b cells, showing that
the absence of calcium influx in NK cells
conjugated with EL4 Rae-1b cells is not
a specificity of this particular cell line.
Furthermore, calcium responses in con-
jugated effectors appeared relatively
homogeneous and we obtained similarresults with two additional tumor cell lines, Bw15.02 and RMA-
S, expressing distinct degrees of activating and inhibitory signals
(Figure S4). These results raised the question of the contribution
of calcium signaling, and in particular extracellular calcium entry,
to NK cell adhesion and cytotoxicity. We thus performed killing
and clustering experiments in presence of 2.5 mM EGTA to
decrease the availability of extracellular calcium. Calcium chela-
tion drastically decreased clustering between OT-I T cells and
EG7 tumor cells (12.3% ± 2.3% of control, p < 0.03), whereas
clustering between NK cells and EL4 Rae-1b tumor cells was
largely unaffected (91.5% ± 6.5% of control) (Figure 7B). Of
note, addition of calcium (2.5 mM CaCl2) reverted clustering of
T cells to control values, further confirming that decrease in
free extracellular calcium was responsible for loss of CTL-EG7
conjugates, but played no substantial role during NK cell conju-
gation. In contrast, chelation of calcium reduced killing efficien-
cies of both NK and CD8+ T cells close to basal amounts (8.2% ±
7.8% of control for specific killing by NK cells, 18.5 ± 7.0% for
specific killing by T cells) (Figure 7C). Thus, even though eleva-
tion of intracellular calcium was limited, calcium influx appeared
Figure 6. NK Cells Are Potent Cytotoxic Effectors Despite Reduced Adhesion to Their Targets
(A) Representative plots of conjugates between purified NK cells or OT-I T cells and tumor cells (EL4, EL4 Rae-1b, or EG7). Effectors and target cells were incu-
bated at 37C for 1 hr to allow conjugate formation before acquisition by flow cytometry. The percentage of effector cells engaged in a conjugate with a target cell
is indicated.
(B) The percentage of clustered effector cells at 1 hr was assessed for NK cells and EL4 or EL4 Rae-1b tumor cells or OT-I T cells and EL4 or EG7 cells. Data are
representative of five independent experiments that were pooled for statistical analysis (p < 0.001).
(C) Clustering of NK cells to EL4 Rae-1b tumor cells (dotted line) or T cells to EG7 cells (full line) for incubation periods ranging from 1 to 6 hr.
(D) Percentage of specific killing of target cells by NK or OT-I T cells at a 5:1 effector: target ratio. Data are representative of at least five experiments.
(E) Specific killing of EL4 and EL4 Rae-1b tumor cells by WT or perforin-deficient (Pfp/) NK cells. Data are representative of two independent experiments.
(F) Percentage of CD107a+ cells among unconjugated NK cells in presence of EL4 and EL4 Rae-1b tumor cells. The dotted line indicates the amount of back-
ground (staining on NK cells alone).
(G) As shown in the upper row, conjugation to tumor cells is analyzed as a function of Ly49C and Ly49I expression. As shown in the lower row, unconjugated NK
cells were assayed for CD107a expression as a function Ly49C and Ly49I expression. Numbers indicate the percentages of Ly49C- or Ly49I-expressing cells
among respectively clustered NK cells (upper row) and among unconjugated CD107a+ NK cells (bottom row). Error bars represent SEM.
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Figure 7. Distinct Intensities and Roles of
Calcium Influxes during NK Cells and CTLs
Interactions with Targets
(A) Effector cells were loaded with the calcium indi-
cator Fluo-3-AM and incubated for 10 min with the
indicated tumor cells (EL4, EL4 Rae-1b, EG7, or
EL4 Rae-1b loaded with 10nM SIINFEKL, referred
to as S8L, peptide) before analysis by flow cytom-
etry. Mean fluorescence intensity in the Fluo-3
channel is plotted for effector cells alone (green)
or effector cells participating in a conjugate (red).
Black lines represent the maximum value of Fluo-
3 signal in the presence of 10 mM ionomycin.
Data are representative of two independent exper-
iments.
(B and C) Percentage of specific clustering (B) and
specific killing (C) in presence or absence of
2.5 mM EGTA and 2.5 mM CaCl2. Values are
expressed as the percentage of specific activity
(e.g., for NK cells, percentage of clustering with
EL4 Rae-1b minus percentage with EL4) in
comparison to controls (no EGTA nor CaCl2).
Data are pooled from two to three independent
experiments (p < 0.001). Error bars represent SEM.
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different patterns of calcium signaling in NK and CD8+ T cells
during effector function. Indeed, calcium influx appears to be
a critical part in both adhesion and cytotoxicity of CD8+ T cells,
and robust conjugation was associated with an important and
sustained elevation of intracellular calcium levels. In sharp
contrast, NK cells only underwent limited or transient calcium
influxes that appeared necessary for cytotoxicity but did not
play a role in the low degree of adhesion to targets. Altogether,
these data suggest that different patterns of calcium influxes
were associated with the distinct behaviors of NK cells and
CTLs during killing.
DISCUSSION
NK cell-based antitumoral therapies are the focus of intense
research (Terme et al., 2008), yet the dynamics of NK cells in
tumors remain poorly understood. In this study, we took advan-
tage of the EL4 tumormodel to induce subcutaneous tumors that
can readily be imaged by two-photon microscopy. Additionally,
a variant of this tumor expressing the NKG2D ligand Rae-1b
(Diefenbach et al., 2001) was used for determining the effect
of NKG2D engagement on NK cell behavior. Our results demon-
strate that NK and CD8+ T cells exert their effector functions with640 Immunity 33, 632–644, October 29, 2010 ª2010 Elsevier Inc.strikingly distinct dynamics and suggest
an important role of calcium influx
patterns in the regulation of effector-
target interactions.
The demonstration that NKG2D ligand
expression induces an increase in intratu-
moral NK cell density and dissemination
extends previous findings that NK cells
accumulate in the peritoneal cavity after
an intraperitoneal (i.p.) injection of MHC
class I-deficient (Glas et al., 2000) orRae-1b-expressing cells (Diefenbach et al., 2001) and show
that the accumulation can also take place within the microenvi-
ronment of a solid tumor. Because NK cell recruitment in tumors
has been shown to be at least partly dependent on IFN-g (Wen-
del et al., 2008), it is possible that activation of the first infiltrating
NK cells by Rae-1b drives additional recruitment through che-
mokine production. Potential candidates include CXCR3 ligands
CXCL 9, 10, and 11 that have been found to be induced by IFN-g
and drive NK cell mobilization (Wald et al., 2006; Wendel et al.,
2008). This hypothesis would be consistent with the high vari-
ability of NK cell infiltration observed in EL4 Rae-1b tumors,
given that NK cell-rich regions would hold the most potential
to attract new NK cells. In addition, such an increase in local
chemokine concentrations may also be responsible for the
elevated NK cell motility we observed in presence of Rae-1b.
Alternatively, cell-intrinsic activation of NK cells through
NKG2D might directly promote their motility. Future studies
comparing the homing and motility of wild-type and NKG2D
deficient NK cells (Guerra et al., 2008) will allow discrimination
of direct and indirect effects of NKG2D recognition.
Although CTL and NK cells induce tumor cell lysis through
similar mechanisms (Russell and Ley, 2003), our results demon-
strate that these two populations display drastically distinct
behaviors in situ. In good agreement with previous studies
Immunity
Distinct Dynamics of NK and CD8+ T Cells in Tumors(Boissonnas et al., 2007; Breart et al., 2008; Mrass et al., 2006),
we found that most tumor-specific CD8+ T cells displayed a
sessile behavior during the early phase of a response and estab-
lished long-lasting contacts (>20 min) during effector function.
NK cells however were motile even in close proximity of tumor
cells and most of them established short-lasting contacts with
target cells (<10 min). Furthermore, our in vitro conjugation
experiments confirmed that NK cells formed significantly less
stable conjugates with their targets despite efficient cytotoxicity.
The previous finding that NK cell cytoskeleton polarization may
be intrinsically slow (Wu¨lfing et al., 2003) could contribute to
this phenomenon. Interestingly, when we imaged NK cell activity
in a different context, namely the lysis of MHC-deficient spleno-
cytes in lymph nodes and compare it to CTL killing of peptide-
pulsed splenocytes, we detected the same differences in
contact dynamics as observed in tumors. Our results extend
the recent findings of Garrod et al. that have analyzed NK cell
killing of allogeneic targets in lymph nodes (Garrod et al., 2010;
Garrod et al., 2007). In this study, NK cell interacted for longer
period of time with allogeneic than with syngeneic cells, yet
most contacts lasted no more than 10 min, a duration substan-
tially shorter than that described for CTL-target contact in vivo
(Breart et al., 2008;Mempel et al., 2006). It is therefore interesting
to consider that the differences of NK cell and CTL dynamics
uncovered in tumors reflect a more general characteristic of their
effector activity.
In vitro (Eriksson et al., 1999; Wu¨lfing et al., 2003) and in vivo
(Garrod et al., 2007) studies have indicated that the lytic hit can
be delivered by NK cells in less than 10 min at least for a fraction
of contacts, suggesting that the contacts lasting 5–10 min in EL4
Rae-1b tumors might be long enough to participate in cytotoxic
function. However, the functional outcome of such interactions
remains to be determined as we only detect physical signs of
lysis, as blebbing, in few instances. Interestingly, a study of
melanoma lysis showed that killing requires several lytic hits
(Caramalho et al., 2009), raising the possibility of an additive
effect of individual short contacts. Alternatively, target cell death
might also be delayed, and thus only occur after the NK cell
detachment, complicating the assessment of killing events.
The ability of NK cells to establish multiple contacts over short
periods could also favor the serial killing capacity that has
been described in vitro (Bhat and Watzl, 2007). Although techni-
cally challenging at the moment, recording the entire contact
history of target and effector cells may allow discrimination
between these possibilities.
Conjugation (Burshtyn et al., 2000) and calcium signaling
(Valiante et al., 1996) in NK cells result from a balance between
activating and inhibiting signals. Likewise, NK cells integrate
both positive and negative signals during spreading and synapse
formation (Culley et al., 2009). It was therefore possible that
expression of MHC class I molecules by tumor cells may have
favored the transient interactions established by NK cells.
Whenwe stained conjugates for inhibitory receptors, it appeared
that Ly49C and Ly49I expression did not substantially alter
conjugation and degranulation in presence of Rae-1b+ tumor
cells, implying that NKG2D signaling largely overrides inhibiting
signals in our model. Furthermore, we did not observe an
increased clustering with cells expressing higher amounts of
Rae-1b or tumor cells lacking MHC I expression, suggestingthat the low clustering of NK cells occurs in a number of different
conditions leading to cytolysis.
To refine our analysis of the divergent behaviors of NK
and CD8+ T cells, we analyzed the role of calcium signaling
during contacts with target cells. Strikingly, whereas virtually
all T cells engaged in conjugates displayed high intracellular
calcium concentrations, NK cells showed at best a weak calcium
elevation during conjugation. Of note, it has been shown that
NKG2D crosslinking by antibodies induces robust calcium
elevation (Jamieson et al., 2002). Our results suggest that a lower
magnitude and duration of calcium elevation is induced during
short-lived interactions between NK cells and their targets. Intra-
cellular calcium influx has been shown to be associated with
a stop signal for T cells (Bhakta et al., 2005), andwe demonstrate
here the requirement of calcium influx for CTL conjugation to
tumor cells. In this respect, the weak calcium response of NK
cells is a likely explanation for their reduced contact durations
in vivo. This rapid disruption of contacts probably leads to
the increased dissemination andmotility of NK cells we observed
in tumor-rich areas, whereas T cells are retained at the border of
such regions by long-lasting contacts. In both cell types, killing
appeared dependent on calcium availability, which is in agree-
ment with previous studies showing calcium dependence on
granule exocytosis (Pores-Fernando and Zweifach, 2009;
Pores-Fernando et al., 2009). Our results thus suggest that
whereas T cells undergo a sustained elevation of intracellular
calcium critical to their adhesion and cytotoxicity, NK cells only
undergo transient and/or limited calcium influxes, which do not
induce strong adhesion but yet remain sufficient for granule
exocytosis. The small amount of NK cell clustering observed in
this study appears to be calcium independent as suggested by
a previous report that has analyzed PLCg2-deficient NK cells
(Caraux et al., 2006).
In conclusion, this study reports the visualization of the role of
NKG2D recognition on NK cell dynamics in a solid tumor. Our
results shed light on drastic differences between CD8+ T cells
and NK cells during effector function with respect to interactions
with target cells and calcium signaling. By using distinct modes
of killing and disseminating differentially in the tumor, NK cells
and CTLs may act synergistically. The existence of these
complementary strategies may offer new perspectives for the
design of immunotherapeutical intervention.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 mice were purchased from Charles River laboratories. Ncr1+/GFP
(Gazit et al., 2006), UBC-GFP (Jackson Laboratories), Rag2/, Rag2/
Il2rg/, and OT-I TCR transgenic mice were bred in our animal facility.
Pfp/ and B2m/ mice were a kind gift from S. Amigorena and M. Albert.
All animal experiments were performed in accordance with institutional guide-
lines for animal care and use.
Tumor cells
EL4 and EG7 tumor cell lines were purchased from the American Type Culture
Collection, EL4 Rae-1b cell line was a kind gift from D. Raulet (Diefenbach
et al., 2001). Membrane-targeted CFP or YFP (mCFP or mYFP) encoding
constructs were cloned in hygro pcDNA3.1 (Invitrogen). Tumor cells were
transfected by electroporation, grown in complete RPMI medium (Invitrogen)
containing the appropriate antibiotic and one clone was selected for each
tumor line. Cells were mycoplasma-free as confirmed with PlasmotestImmunity 33, 632–644, October 29, 2010 ª2010 Elsevier Inc. 641
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phase and 5 3 106 cells in 50 ml of PBS were injected subcutaneously (s.c.)
in the leg. Tumor volumes were monitored every 2 days with a caliper (Mitu-
toyo) and volumes were calculated under the assumption that tumors were
half-spherical.
Cell Purification and Adoptive Transfer
NK cells were purified by negative selection from Rag2/ UBC-GFP mice
with the NK cell isolation kit (Miltenyi) in accordance to the manufacturer’s
instructions. Four days after transfer, more than 95% of GFP+ cells were
NK1.1+ in the spleen and the tumor. For CTL generation, spleens from
OT-I UBC-GFP mice were harvested, dissociated on a cell strainer, and
activated for 4 days in complete RPMI with 25U/mL IL-2 (Roche) and 10 nM
SIINFEKL (NeoMPS). More than 98%of injected cells were CD8+. For adoptive
transfer, 2 3 106 NK or CD8+ T cells were injected intravenously (i.v.) into
tumor-bearing mice.
Confocal imaging
Tumors were excised 4 days after NK cell injection, fixed in paraformaldehyde-
lysine-periodate, dehydrated in sucrose, and snap-frozen inOCT (Sakura Fine-
tek). Ten-micrometer-thick sections were rehydrated (six consecutive sections
were collected every 100 mm throughout the entire tumor), blocked with anti-
CD16/32 (clone 93, eBiosciences), and stained with biotin-anti-PECAM-1
mAb (clone ER-MP12, BMA) and then PE-conjugated streptavidin (PharMin-
gen). Sectionswere thenmounted in Vectashieldmedium (Vector Laboratories)
and imagedwith a confocalmicroscope (DM6000B, LeicaMicrosystems). Data
were processed with the ImageJ software (NIH, version 1.40).
Flow Cytometry
Spleen and tumors from mice were collected 4 days after NK cell transfer and
dissociated in RPMI containing 1 mg/mL collagenase and 0.05 mg/mL DNase
(Sigma). After Fc-receptor blocking, cells were stained with PE-Cy7-conju-
gated anti-NK1.1 (PK136) and biotin-coupled anti-NKG2D (CX5) and then
APC-conjugated streptavidin (eBiosciences). For intracellular staining, cells
were fixed and permeabilized with Cytofix/Cytoperm Kit (BD Biosciences),
washed, and stained with APC-conjugated anti-granzyme B (clone GB11,
Invitrogen) in presence of anti-CD16/32. Acquisition was performed on
a FACS Canto II cytometer (BD) and data were analyzed on FlowJo (TreeStar,
version 8.8.2).
Intravital Two-Photon Imaging
Intravital tumor imaging was realized as described previously (Breart et al.,
2008). In brief, anesthetized mice were placed on a custom-made heated
stage and the skin above the tumor was carefully removed. The leg was immo-
bilized with a plaster cast and a coverslip attached to a heated metal ring was
set on top of the tumor to maintain the temperature at 37C. For the visualiza-
tion of NK and CTL activity in lymph nodes, GFP+ endogenous NK cells were
activated with polyI:C or preactivated GFP+ OT-I T cells were adoptively trans-
ferred in a B6 mouse. A total of 1 3 107 SNARF-labeled targets (respectively
B2m/ or SIINFEKL-pulsed splenocytes) were injected after 18 hr, and
imaging was performed on explanted lymph nodes 2 hr after injection. Two-
photon imaging was performed on an upright microscope (DM6000B, Leica
Microsystems) with a water-dipped 203/0.95NA objective (Olympus). Sample
excitation was provided by a Ti:sapphire laser (Coherent) tuned at 950 nm and
emitted fluorescence was collected with four non-descanned detectors (Leica
Microsystems). Typically, we recorded 5 to 10 z slices separated by 5 mmevery
30 s for 30 min. Movies were then processed with the ImageJ software and
analyzed with Imaris (Bitplane, version 5.7). For measuring the impact of tumor
cell density on NK and T cell behavior, projections of the movies were split in
53 5 regions in the x and y directions. In each of these regions, we quantified
the mean fluorescence intensity of tumor signal, the number of effector cells
(averaged over time), and the mean instant velocity of effector cells. Contacts
were defined as the absence of black pixels between two cells in at least one
plane and two consecutive images. Contact durations correspond to the
amount of time effector cells were seen interacting with a single target cell
during a 30 min movie and thus represent a minimal estimation of the actual
contact time.642 Immunity 33, 632–644, October 29, 2010 ª2010 Elsevier Inc.Conjugation and Cytotoxicity Assays
NK cells were negatively purified from the spleens of Ncr1+/GFP mice injected
18 hr before with 250 mg of polyI:C i.p. OT-I CTLs were prepared and activated
as described above. When indicated, EL4 Rae-1b tumor cells were pulsed
with 10nM SIINFEKL peptide in serum-free medium for 20 min at room
temperature. Effector cells were labeled with 1 mM Far Red DDAO-SE and
target cells with 10 mM Cell Tracker Blue (Invitrogen). Effectors (1 3 105cells)
and targets (4 3 105) were mixed in 200 ml complete RPMI, spun for 1 s at
1200 rpm, and incubated 1 hr at 37C before conjugates were quantified by
flow cytometry. For NK cells, contaminating cells were excluded from the
analysis on the basis of the GFP fluorescence. For additional stainings, clus-
ters were performed for 1 hr in presence of Alexa 647-conjugated anti-
CD107a (clone 1D4B, eBiosciences). Conjugation was stopped after 1 hr
with cold PBS 2% FCS. Cells were then incubated for 20 min at 4C
with PE-conjugated anti-Ly49C/I (clone 5E6, BD Biosciences) and washed
before acquisition. Identical tubes without antibody or incubation at 4C
were run in parallel to control that the procedure only minimally affected conju-
gation efficiency. For killing experiments, effector and target cells were mixed
at a 5:1 effector/target ratio in 96-well plates and spun 1 s at 1200 rpm. After
6 hr, remaining target cells were counted by flow cytometry with Caltag
counting beads (Invitrogen). Cell viability was assessed with propidium iodide
(Sigma). Data are presented as the percentage of specific killing, calculated
as 1003 (1 target cells in well/target cells in well without effectors). Measure-
ment of intracellular calcium concentrations was performed as described
before (Beuneu et al., 2009): effectors were loaded with 5 mM Fluo-3 in
RPMI + 0.2% Pluronic (Sigma) for 30 min, washed, and incubated with
targets cells for 10 min before sample acquisition. When indicated, RPMI
(0.424 mM free Ca2+) was supplemented with 2.5 mM EGTA (final concentra-
tion of 43nM free Ca2+) or 2.5 mM EGTA and 2.5 mM CaCl2 (0.422 mM free
Ca2+) (Sigma).
Statistics
All statistical analyses were performed with a Mann-Whitney Wilcoxon
unpaired test and KaleidaGraph software (Synergy software, v4.03). p values
lower than 0.05 were considered significant. All data are presented as
mean ± SEM.
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